Results 201 to 210 of about 39,262 (226)

Pharmacotherapy for Postmenopausal Osteoporosis

JAMA, 2021
openaire   +2 more sources

Drugs for Postmenopausal Osteoporosis

The Medical Letter on Drugs and Therapeutics
Pharmacologic treatment is recommended for postmenopausal women who have bone density T-scores (standard deviations from normal mean values in the spine, femoral neck, total hip, or distal radius) of -2.5 or below, T-scores between -1.0 and -2.5 with a history of fragility (low-trauma) fracture of the hip or spine, or T-scores between -1.0 and -2.5 ...
openaire   +2 more sources

POSTMENOPAUSAL OSTEOPOROSIS

The Lancet, 1979
openaire   +2 more sources

Postmenopausal Osteoporosis

New England Journal of Medicine, 2005
openaire   +2 more sources

Senile and Postmenopausal Osteoporosis

Hormone Research, 2008
M, Peacock, A, Horsman, D H, Marshall, J E, Aaron, R M, Francis, P L, Selby   +5 more
openaire   +2 more sources

Pharmacological Management of Postmenopausal Osteoporosis: a Level I Evidence Based - Expert Opinion

Expert Review of Clinical Pharmacology, 2021
Filippo Migliorini, Alice Baroncini
exaly  

VI. Meta-Analysis of Calcitonin for the Treatment of Postmenopausal Osteoporosis

Endocrine Reviews, 2002
Peter Tugwell, Jonathan Adachi, Wells G A   +2 more
exaly  

Postmenopausal Osteoporosis

Endocrinology and Metabolism Clinics of North America, 2021
exaly  

IV. Meta-Analysis of Raloxifene for the Prevention and Treatment of Postmenopausal Osteoporosis

Endocrine Reviews, 2002
Peter Tugwell, Jonathan Adachi, Wells G A   +2 more
exaly  

Relationship between postmenopausal osteoporosis and the components of clinical sarcopenia

Maturitas, 2013
Toni Rikkonen, Heikki Kröger, Risto Honkanen   +2 more
exaly